Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

Bob T. Li, Leena Gandhi, Vignesh Ravichandran, Benjamin Besse, Julien Mazières, Geoffrey I. Shapiro, Valentina Boni, Saiama N. Waqar, Haeseong Park, David I. Quinn, Alejandro Martinez, Salomon M. Stemmer, Alexis B. Cortot, Fabrice Barlesi, Elisabeth Quoix, Mark E. Burkard, S. Duygu Selcuklu, Casey Hunt, Mark T.A. Donoghue, Mark G. Kris, Judith Bebchuk, Lisa D. Eli, Leanne McCulloch, David B. Solit, Pasi A. Jänne

Open source

DOI: 10.1016/j.cllc.2025.09.009
Published: 2026-03
Container: Clinical Lung Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.cllc.2025.09.009,
  title = {Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies},
  author = {Bob T. Li and Leena Gandhi and Vignesh Ravichandran and Benjamin Besse and Julien Mazières and Geoffrey I. Shapiro and Valentina Boni and Saiama N. Waqar and Haeseong Park and David I. Quinn and Alejandro Martinez and Salomon M. Stemmer and Alexis B. Cortot and Fabrice Barlesi and Elisabeth Quoix and Mark E. Burkard and S. Duygu Selcuklu and Casey Hunt and Mark T.A. Donoghue and Mark G. Kris and Judith Bebchuk and Lisa D. Eli and Leanne McCulloch and David B. Solit and Pasi A. Jänne},
  year = {2026},
  journal = {Clinical Lung Cancer},
  doi = {10.1016/j.cllc.2025.09.009},
  url = {https://doi.org/10.1016/j.cllc.2025.09.009}
}

RIS

TY  - JOUR
TI  - Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies
AU  - Bob T. Li
AU  - Leena Gandhi
AU  - Vignesh Ravichandran
AU  - Benjamin Besse
AU  - Julien Mazières
AU  - Geoffrey I. Shapiro
AU  - Valentina Boni
AU  - Saiama N. Waqar
AU  - Haeseong Park
AU  - David I. Quinn
AU  - Alejandro Martinez
AU  - Salomon M. Stemmer
AU  - Alexis B. Cortot
AU  - Fabrice Barlesi
AU  - Elisabeth Quoix
AU  - Mark E. Burkard
AU  - S. Duygu Selcuklu
AU  - Casey Hunt
AU  - Mark T.A. Donoghue
AU  - Mark G. Kris
AU  - Judith Bebchuk
AU  - Lisa D. Eli
AU  - Leanne McCulloch
AU  - David B. Solit
AU  - Pasi A. Jänne
PY  - 2026
JO  - Clinical Lung Cancer
DO  - 10.1016/j.cllc.2025.09.009
UR  - https://doi.org/10.1016/j.cllc.2025.09.009
ER  -

APA

Li, B. T., Gandhi, L., Ravichandran, V., Besse, B., Mazières, J., Shapiro, G. I., Boni, V., Waqar, S. N., Park, H., Quinn, D. I., Martinez, A., Stemmer, S. M., Cortot, A. B., Barlesi, F., Quoix, E., Burkard, M. E., Selcuklu, S. D., Hunt, C., Donoghue, M. T., Kris, M. G., Bebchuk, J., Eli, L. D., McCulloch, L., Solit, D. B., & Jänne, P. A. (2026). Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2025.09.009

Source records

crossref · retrieved 2026-09-26T13:09:25.508Z